Endometrial Adenocarcinoma
📧 Sign up to get email alerts when something new happens for Endometrial Adenocarcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-09-05Clinical Trial Update: Akt Inhibitor MK2206 in Treating Patients With Recurrent or Advanced Endometrial Cancer [Phase 2]
Phase 2 trial evaluating MK2206, an Akt inhibitor, in recurrent or advanced endometrial cancer; study completed with results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-08-28Clinical Trial Update: Cediranib Maleate in Treating Patients With Recurrent or Persistent Endometrial Cancer [Phase 2]
Phase 2 clinical trial evaluating cediranib maleate for recurrent or persistent endometrial cancer has been completed with results posted.
-
CLINICAL_TRIALS trial_result · 2016-02-05Clinical Trial Update: Dalantercept in Treating Patients With Recurrent or Persistent Endometrial Cancer [Phase 2]
A Phase 2 clinical trial evaluating dalantercept for recurrent or persistent endometrial cancer has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2015-05-21Clinical Trial Update: Ixabepilone in Treating Patients With Recurrent or Persistent Endometrial Cancer [Phase 2]
Phase 2 trial update of ixabepilone in patients with recurrent or persistent endometrial cancer; completed with posted results in 2015.
-
CLINICAL_TRIALS trial_result · 2015-02-23Clinical Trial Update: Temsirolimus in Treating Patients With Metastatic or Locally Advanced Recurrent Endometrial Cancer [Phase 2]
A Phase 2 clinical trial evaluated temsirolimus in patients with metastatic or locally advanced recurrent endometrial cancer, with results p…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-12-31Clinical Trial Update: Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer [Phase 1]
Phase 1 trial evaluating the safety of combining chemotherapy with radiation therapy for stage III or stage IV endometrial cancer has comple…
-
CLINICAL_TRIALS trial_result · 2014-08-15Clinical Trial Update: Medroxyprogesterone in Treating Patients With Endometrioid Adenocarcinoma of the Uterine Corpus [Phase 2]
A Phase 2 clinical trial evaluated medroxyprogesterone acetate for treating endometrial cancers, including endometrial adenocarcinoma and re…
-
CLINICAL_TRIALS trial_result · 2014-02-24Clinical Trial Update: Intensity-Modulated Radiation Therapy, Cisplatin, and Bevacizumab Followed by Carboplatin and Paclitaxel in Treating Patients Who Have Undergone Surgery for Endometrial Cancer [Phase 2]
This Phase II clinical trial update evaluates a multimodal therapy consisting of intensity-modulated radiation therapy with cisplatin and be…
-
CLINICAL_TRIALS trial_result · 2014-01-20Clinical Trial Update: Selumetinib in Treating Patients With Recurrent or Persistent Endometrial Cancer [Phase 2]
Phase 2 trial of selumetinib in recurrent or persistent endometrial cancer has completed with results posted in 2014.
-
CLINICAL_TRIALS trial_result · 2013-01-24Clinical Trial Update: Thalidomide in Treating Patients With Recurrent or Persistent Endometrial Cancer [Phase 2]
Phase 2 trial evaluating thalidomide in patients with recurrent or persistent endometrial cancer has completed.